CN113355254A - Formula and application of starter protective agent - Google Patents
Formula and application of starter protective agent Download PDFInfo
- Publication number
- CN113355254A CN113355254A CN202010311191.9A CN202010311191A CN113355254A CN 113355254 A CN113355254 A CN 113355254A CN 202010311191 A CN202010311191 A CN 202010311191A CN 113355254 A CN113355254 A CN 113355254A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- starter
- percent
- mannitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007858 starting material Substances 0.000 title claims abstract description 61
- 239000003223 protective agent Substances 0.000 title abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 45
- 239000000203 mixture Substances 0.000 claims abstract description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 28
- 238000009472 formulation Methods 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 25
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 17
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 17
- 229930195725 Mannitol Natural products 0.000 claims abstract description 17
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 17
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 17
- 239000000594 mannitol Substances 0.000 claims abstract description 17
- 235000010355 mannitol Nutrition 0.000 claims abstract description 17
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 14
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 14
- 239000011718 vitamin C Substances 0.000 claims abstract description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 13
- 239000011734 sodium Substances 0.000 claims abstract description 13
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 13
- 241000589776 Pseudomonas putida Species 0.000 claims description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 18
- 241000894006 Bacteria Species 0.000 claims description 15
- 241000192125 Firmicutes Species 0.000 claims description 4
- 230000001012 protector Effects 0.000 claims 7
- 239000012535 impurity Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 29
- 230000001681 protective effect Effects 0.000 description 22
- 230000004083 survival effect Effects 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 12
- 238000012258 culturing Methods 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 8
- 239000010802 sludge Substances 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 240000006024 Lactobacillus plantarum Species 0.000 description 5
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 229940072205 lactobacillus plantarum Drugs 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 4
- 235000013923 monosodium glutamate Nutrition 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003124 biologic agent Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000004223 monosodium glutamate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FXXMDJFRMDVSCF-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hydrate Chemical compound O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O FXXMDJFRMDVSCF-RXSVEWSESA-N 0.000 description 1
- QNURTFDBHAQRSI-OAHLLOKOSA-N (4r)-3-[4-[[2-[(3-iodophenyl)methyl]-3-oxocyclohexen-1-yl]amino]phenyl]-4-methyl-4,5-dihydro-1h-pyridazin-6-one Chemical compound C[C@@H]1CC(=O)NN=C1C(C=C1)=CC=C1NC(CCCC1=O)=C1CC1=CC=CC(I)=C1 QNURTFDBHAQRSI-OAHLLOKOSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- HVUMOYIDDBPOLL-XGKPLOKHSA-N [2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XGKPLOKHSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- -1 amino acid sodium salt Chemical class 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 235000021001 fermented dairy product Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a formula of a starter protective agent and application thereof. A starter protectant formulation comprising: 1.125 +/-10 to 4.5 +/-10 weight percent of trehalose; 2.25 +/-10 to 4.5 +/-10 weight percent of skimmed milk powder; 1.125 +/-10% to 2.25 +/-10% by weight of mannitol; 0.0225 +/-10% to 0.1125 +/-10% by weight of vitamin C; 0.225 plus or minus 10 percent to 1.125 plus or minus 10 percent of sodium glutethionine by weight; and 0.225 +/-10% to 1.125 +/-10% of glycerol by weight.
Description
Technical Field
The invention relates to a starter (starter) protectant formula, in particular to a starter protectant formula which is suitable for gram-positive bacteria and gram-negative bacteria simultaneously.
Background
Since the number of bacteria of natural microorganisms is usually not as large as that required for practical use, and it is not easy to preserve the microorganisms, and the microorganisms are often stimulated by the environment or mutated after many generations of culture, they are often used and circulated in the form of "starters" which are hot air-dried or freeze-dried. In the food industry, for example, natural bacteria cannot be used directly when fermentation is required by microorganisms in the process because of the large operation volume. Usually, domesticated starter is used to perform propagation in advance, and the subsequent process is performed after sufficient bacteria number is reached. Practical industrial applications include, for example, industries that require yeast as a raw material, such as: beer fermentation and bread baking industries. In addition, as applied to the agricultural biological agent industry, the biological agent products produced are also required to have a high and stably maintained viable cell count, and therefore, the method is also suitable for the first propagation with a starter. Therefore, after the development of the characteristic potential strains, a starter formula is needed, which can achieve the purposes of high stability and high viable count, thereby increasing the application flexibility in the process. Meanwhile, the thalli can be sold in a starter form, so that the speed and the diversity of product innovation are increased.
CN106244459A discloses a dry pseudomonas powder and a preparation method thereof, wherein the dry pseudomonas powder comprises pseudomonas and a protective agent, wherein the protective agent comprises skimmed milk powder, mannitol, sodium glutamate or glycine, corn starch and trehalose.
CN107828683A discloses a lactobacillus plantarum freeze-dried powder for prolonging the shelf life of yogurt and a preparation method thereof, which is characterized in that lactobacillus plantarum freeze-dried powder is prepared by mixing lactobacillus plantarum strains and an emulsion protective agent and freeze-drying, wherein the lactobacillus plantarum strains are stored in China general microbiological culture Collection center (CGMCC), and the preservation number is CGMCC number 10453. The preparation method comprises the steps of strain activation, strain propagation, fermentation culture and freeze-drying. The lactobacillus plantarum freeze-dried powder has an inhibiting effect on main putrefying mold and yeast in the fermented dairy product.
The existing starter protective agent formula has the defect of low viable count during culture, and particularly, the viable count is greatly reduced when the starter protective agent formula is used after a period of time after preparation is finished.
Disclosure of Invention
The main object of the present invention is to provide a starter protectant formulation that can improve the disadvantages of low viable count and survival rate, and in particular a starter protectant formulation with improved stability, which still has comparable viable count after a period of storage compared to the starter protectant formulation just prepared.
The invention aims to provide a formula of a starter protective agent, which comprises the following components:
1.125 +/-10% by weight of trehalose;
2.25 plus or minus 10 percent of skimmed milk powder;
1.125 plus or minus 10 percent of mannitol;
0.0225 plus or minus 10% by weight of vitamin C;
0.225 plus or minus 10 percent of sodium glutethinate; and
0.225 + -10% parts by weight of glycerol.
Other preferred embodiments of the present invention include, but are not limited to, those described in the following claims.
The starter protectant formulation of the present invention has the feature of improved viable count and survival rate whether used for the culture of gram-positive or gram-negative bacteria.
Drawings
FIG. 1 shows the viable cell count of a Pseudomonas putida starter cultured at 30 ℃ for 72 hours, which was prepared for each protective solution group in Table 1 of example 1 of the present invention.
FIGS. 2 to 4 show the viable cell counts of yeast cells 21849, 20405 and 22745, respectively, prepared from the respective protective solutions in Table 1 of example 1 of the present invention, after culturing at 25 ℃ for 72 hours.
FIG. 5 shows the viable cell count of a Pseudomonas putida starter prepared for each of the protective solutions in tables 2 and 3 of comparative example 1 after culturing at 30 ℃ for 72 hours.
FIG. 6 shows viable cell counts of yeast cells 21849, 20405 and 22745 starting materials prepared from the respective protective solutions in Table 2 and Table 3 of comparative example 1 after culturing at 25 ℃ for 72 hours.
FIG. 7 shows the survival rate of Pseudomonas putida starter cultured at 30 ℃ for 72 hours, prepared for each protection solution group in Table 1 of example 1 of the present invention.
FIGS. 8 to 10 show the survival rates of the starters 21849, 20405 and 22745 of yeast strains prepared from the respective protective solutions in Table 1 of example 1 of the present invention after culturing at 25 ℃ for 72 hours, respectively.
FIG. 11 shows the survival rate of Pseudomonas putida starter cultured at 30 ℃ for 72 hours, prepared for each of the protective solution groups in Table 2 and Table 3 of comparative example 1.
FIG. 12 shows the survival rates of the starters for yeast 21849, 20405 and 22745 prepared in each of the protective solutions in Table 2 and Table 3 of comparative example 1 after culturing at 25 ℃ for 72 hours.
FIG. 13 shows the number of viable bacteria of a Pseudomonas putida starter prepared from each of the protective solutions in Table 1 of example 1 of the present invention and cultured at 30 ℃ for 72 hours after being stored at 25 ℃ and 54 ℃ for 14 days.
Detailed Description
The present invention and its improvements will be further understood by the following examples and comparative examples. The following materials and instruments were used in the following examples and comparative examples.
Material
Defatted milk powder | MERCK |
Casein protein | MERCK |
Glycerol | SIGMA |
Vitamin C | SIGMA |
Trehalose | SIGMA |
Sucrose | SIGMA |
Bran amino acid sodium salt (monosodium glutamate) | All- |
Span | |
60 | SIGMA |
YM Broth | Gibico |
Formula of Pseu F agar culture medium
| MERCK | |
1% of trypsinization protein | MERCK | |
Dipotassium hydrogen phosphate (K)2HPO4) 0.15% | SIGMA | |
Magnesium sulfate (MgSO)4) 0.15% | SIGMA | |
Agar (Agar) | SIGMA |
Instrument for measuring the position of a moving object
Pseudomonas putida culture method
Selected pseudomonas putida YLW01 (Pseudomonas putida) Are experimental strains. YLW01 was cultured in a medium containing 1% Molasses, 1% MSG, 1.5 g/L K2HPO4With 1.5 g/L MgSO4 .7H2O medium (50 mL medium/250 mL Erlenmeyer flask) was cultured at 30 ℃ and 150 rpm for 42 hr. After completion of the incubation, the cells were centrifuged at 8000 rpm for 10 minutes at 4 ℃, the supernatant was discarded, washed with water and centrifuged again, and this washing process was repeated twice. And taking out the centrifuged bacterial sludge and storing the bacterial sludge in a refrigerator.
Culture method of yeast
Yeasts 21849, 20405 and 22745 are selected as experimental strains. Yeasts 21849, 20405 and 22745 were cultured in YM broth (Becton Dickinson and Company) (50 mL medium/250 mL Erlenmeyer flask) and cultured at 25 ℃ and 250 rpm for 48 hr. After completion of the incubation, the cells were centrifuged at 8000 rpm for 10 minutes at 4 ℃, the supernatant was discarded, washed with water and centrifuged again, and this washing process was repeated twice. And taking out the centrifuged bacterial sludge and storing the bacterial sludge in a refrigerator.
Formulation of protective agent/preparation of protective liquid
The protective solution was prepared by dissolving the protective agent formulation shown in table 1 in 22.5 mL of water, and after stirring for 30 minutes until the solution was uniform, pH was adjusted to 7 or 8 using the following phosphate solution (adjusted from alkaline to acidic) or glycine-sodium hydroxide buffer (adjusted from acidic to alkaline).
Table 1: formula (g) of protective agent/protective solution (g/vol%)
Preparing a glycine-sodium hydroxide buffer solution:
50 mL of an aqueous glycine solution (0.2M) and 8.8 mL of an aqueous sodium hydroxide solution (0.2M) were mixed uniformly and then the mixture was quantified to 200 mL.
Preparing a phosphate solution:
87.7 mL of an aqueous solution of sodium dihydrogenphosphate (0.2M) and 12.3 mL of an aqueous solution of sodium monohydrogenphosphate (0.2M) were mixed uniformly and then the mixture was quantified to 200 mL.
Example 1
Preparation of bottle opener
Taking the prepared bacterial sludge out of the refrigerator, mixing 7.5 g of bacterial sludge with each protective solution in the table 1 respectively, stirring for 30 minutes until the bacterial sludge is uniformly mixed, pre-freezing at the temperature of minus 20 ℃, and freeze-drying to obtain the starter.
1 g of the freshly prepared freeze-dried starter is taken to be redissolved in 10 mL of water, serial dilution with proper multiplying power is carried out, 100 mu L of starter dilution is taken to be smeared on a Pseu F culture medium, and colony counting is carried out after culture is carried out at 30 ℃ for 72 hours.
Comparative example 1
The starter was prepared according to the above-mentioned formulations of CN106244459 and CN 107828683. 22.5 mL of the protective solutions shown in tables 2 and 3 were mixed with 7.5 g of the prepared bacterial sludge, respectively, and the mixture was stirred for 30 minutes until the mixture was uniform, then prefreezed at-20 ℃ and freeze-dried to obtain a starter of comparative example 1.
1 g of the freshly prepared freeze-dried starter is taken to be redissolved in 10 mL of water, serial dilution with proper multiplying power is carried out, 100 mu L of starter dilution is taken to be smeared on a Pseu F culture medium, and colony counting is carried out after culture is carried out at 30 ℃ for 72 hours.
TABLE 2 CN106244459 protective solution (g/vol%)
Group of | Trehalose (%) | Skimmed milk powder (%) | Mannitol (%) | Yeast powder (%) | Monosodium glutamate (%) | Span60(%) | Glycine (%) | Corn starch (%) |
CN106244459-1 | 1 | 25 | 0.5 | 1 | 3 | 2 | 3 | 0.1 |
CN106244459-2 | 5 | 12 | 5 | 3 | 0 | 1 | 15 | 2 |
TABLE 3 CN107828683 protective solution (g/vol%)
Group of | Trehalose (%) | Skimmed milk powder (%) | Glycerol (%) | Mannitol (%) | Sucrose (%) | Ascorbic acid | Water (W) |
|
6 | 8 | 1 | 2 | 4 | 0.5 | 78.5 |
Results
FIG. 1 shows the viable cell count of a Pseudomonas putida starter cultured at 30 ℃ for 72 hours, which was prepared for each protection solution group in Table 1 of example 1. In FIG. 1, it was found that the viable count of Pseudomonas putida was maintained at 109CFU/g above, the protective agent of the invention has good protective effect. It is composed ofThe highest viable count of the Chinese and Japanese medicinal herbs in group 2 reaches 6.3x109 CFU/g。
FIGS. 2 to 4 show the viable cell counts of yeast 21849, 20405 and 22745 starters prepared from the respective protective solutions in Table 1 of example 1 after culturing at 25 ℃ for 72 hours, respectively. The viable count of yeast 21849, 20405 and 22745 is 3.44 × 109CFU/g (FIG. 2 group 5), 3.75x109CFU/g (FIG. 3 group 7) and 5x109CFU/g (FIG. 4, group 3).
FIG. 5 shows the viable cell count of a Pseudomonas putida starter prepared for each of the protective solutions in tables 2 and 3 of comparative example 1 after culturing at 30 ℃ for 72 hours. In FIG. 5, the viable count of Pseudomonas putida was found to be 5.8X10 respectively7、8.8x108And 2.6x108 CFU/g。
FIG. 6 shows viable cell counts of yeast cells 21849, 20405 and 22745 starting materials prepared from the respective protective solutions in Table 2 and Table 3 of comparative example 1 after culturing at 25 ℃ for 72 hours. The culture effect is not good, and the number of most viable bacteria is 108CFU/g, the highest viable count group is yeast 22745 and uses CN106244459-2 formula, reaching 1.99x109 CFU/g。
FIG. 7 shows the survival rate of Pseudomonas putida starter cultured at 30 ℃ for 72 hours, prepared for each protection solution group in Table 1 of example 1. The survival rate calculation method is as follows:
survival (%) = [ viable cell count after lyophilization (CFU)/number of cells added before lyophilization (CFU) ] + 100%
In FIG. 7, it was found that the viable count of P.putida was maintained at 15% or more, with the highest survival rate of about 78% in group 2. The survival performance of each group in fig. 7 is similar to the viable count performance of fig. 1.
FIGS. 8 to 10 show the survival rates of yeast 21849, 20405 and 22745 starters prepared from the respective protective solutions in Table 1 of example 1 after culturing at 25 ℃ for 72 hours, respectively. The survival rates of yeast 21849, 20405 and 22745 were 53.22% (fig. 8, group 3), 47.2% (fig. 9, group 3) and 47.41% (fig. 10, group 3), respectively.
FIG. 11 shows the survival rate of Pseudomonas putida starter cultured at 30 ℃ for 72 hours, prepared for each of the protective solution groups in Table 2 and Table 3 of comparative example 1. The survival rates for P.putida were found to be 0.07%, 1.02% and 0.3% in FIG. 11, respectively.
FIG. 12 shows the survival rates of the starters for yeast 21849, 20405 and 22745 prepared in each of the protective solutions in Table 2 and Table 3 of comparative example 1 after culturing at 25 ℃ for 72 hours. FIG. 12 shows the survival rate of the same trend as that of FIG. 6, which is about 2%, wherein the highest group is CN106244459-1 cultured in yeast 20405.
As can be seen from FIGS. 1 to 12, the tests of the formulations of the present invention and the former formulations with P.putida and 3 yeasts (21849, 20405 and 22745) revealed that the viable count and survival rate of the formulations of the present invention were significantly improved compared to the former formulations CN106244459-1, CN106244459-2 and CN 107828683. The unexpected enhancement effect of the invention is proved.
Example 2: freeze-dried bottle opener stability test
The freeze-dried starter prepared in example 1 was stored at 25 ℃ and 54 ℃ for 14 days, 1 g of the starter was redissolved in 10 mL of water, and serially diluted at an appropriate ratio, 100. mu.L of a dilution of Pseudomonas putida starter was applied to a Pseu F medium, and cultured at 30 ℃ for 72 hours, followed by colony counting.
The results are shown in fig. 13, which also shows the viable count of the freshly prepared freeze-dried starter. FIG. 13 shows that the viable cell counts of most formulation groups are significantly reduced and the maximum reduction is achieved in group 2 after culturing the Pseudomonas putida starter prepared from each of the protection solution groups in Table 1 of example 1 of the present invention at 30 ℃ for 72 hours after storage at 25 ℃ for 14 days, but the viable cell counts are still maintained at 2X 108CFU/g. Group 4 had the smallest descending extent and the number of viable bacteria reached 1.2 x109CFU/g, and maintained survival above 87% (not shown). From the results of the culture after storage at 54 ℃ for 14 days in FIG. 13, it was found that the number of viable bacteria was greatly decreased, and the number of viable bacteria in most groups was decreased to 107Below CFU/g, only groups 3, 4 and 7 remain at 107CFU/g or more, and the highest viable count of group 7 is 6.2 x107CFU/g. Jelly of the inventionThe dried starter has good stability, and can maintain 2 x10 after being stored for 14 days at 25 deg.C8The viable count above CFU/g is only about one log lower than that of the freeze-dried starter which is just prepared.
Claims (14)
1. A starter protectant formulation comprising:
1.125 +/-10 to 4.5 +/-10 weight percent of trehalose;
2.25 +/-10 to 4.5 +/-10 weight percent of skimmed milk powder;
1.125 +/-10% to 2.25 +/-10% by weight of mannitol;
0.0225 +/-10% to 0.1125 +/-10% by weight of vitamin C;
0.225 plus or minus 10 percent to 1.125 plus or minus 10 percent of sodium glutethionine by weight; and
0.225 +/-10% to 1.125 +/-10% by weight of glycerol.
2. The starter protector formulation of claim 1, further comprising gram positive bacteria.
3. The starter protectant formulation of claim 2, wherein the gram-positive bacteria is a yeast.
4. The starter protector formulation of claim 1, further comprising gram negative bacteria.
5. A starter protector formulation as claimed in claim 4, wherein the gram-negative bacterium is Pseudomonas putida (Pseudomonas putida).
6. A starter protector formulation as claimed in any one of claims 1 to 5 comprising:
1.125 +/-5 to 4.5 +/-5 weight percent of trehalose;
2.25 +/-5 to 4.5 +/-5 weight percent of skimmed milk powder;
1.125 +/-5 to 2.25 +/-5 weight percent of mannitol;
0.0225 + -5% to 0.1125 + -5% by weight of vitamin C;
0.225 plus or minus 5 percent to 1.125 plus or minus 5 percent of sodium glutethinate in weight portion; and
0.225 +/-5% to 1.125 +/-5% by weight of glycerol.
7. The starter protector formulation of claim 6 comprising a group selected from the group consisting of groups 1 to 8:
group 1:
1.125 parts by weight of trehalose;
2.25 parts by weight of skimmed milk powder;
1.125 parts by weight of mannitol;
0.0225 parts by weight of vitamin C;
0.225 parts by weight of sodium glutethinate; and
0.225 parts by weight of glycerol;
group 2:
1.125 parts by weight of trehalose;
2.25 parts by weight of skimmed milk powder;
2.25 parts by weight of mannitol;
0.1125 parts by weight of vitamin C;
1.125 parts by weight of sodium glutethinate; and
1.125 parts by weight of glycerol;
group 3:
4.5 parts by weight of trehalose;
4.5 parts by weight of skimmed milk powder;
1.125 parts by weight of mannitol;
0.0225 parts by weight of vitamin C;
1.125 parts by weight of sodium glutethinate; and
1.125 parts by weight of glycerol;
group 4:
4.5 parts by weight of trehalose;
4.5 parts by weight of skimmed milk powder;
2.25 parts by weight of mannitol;
0.1125 parts by weight of vitamin C;
0.225 parts by weight of sodium glutethinate; and
0.225 parts by weight of glycerol;
group 5:
1.125 parts by weight of trehalose;
4.5 parts by weight of skimmed milk powder;
1.125 parts by weight of mannitol;
0.1125 parts by weight of vitamin C;
0.225 parts by weight of sodium glutethinate; and
1.125 parts by weight of glycerol;
group 6:
1.125 parts by weight of trehalose;
4.5 parts by weight of skimmed milk powder;
2.25 parts by weight of mannitol;
0.0225 parts by weight of vitamin C;
1.125 parts by weight of sodium glutethinate; and
0.225 parts by weight of glycerol;
group 7:
4.5 parts by weight of trehalose;
2.25 parts by weight of skimmed milk powder;
1.125 parts by weight of mannitol;
0.1125 parts by weight of vitamin C;
1.125 parts by weight of sodium glutethinate; and
0.225 parts by weight of glycerol;
group 8:
4.5 parts by weight of trehalose;
2.25 parts by weight of skimmed milk powder;
2.25 parts by weight of mannitol;
0.0225 parts by weight of vitamin C;
0.225 parts by weight of sodium glutethinate; and
1.125 parts by weight of glycerol.
8. A starter protector formulation as claimed in any one of claims 1 to 5 which is in powder form.
9. A starter protector formulation as claimed in claim 1 which consists of:
1.125 +/-10 to 4.5 +/-10 weight percent of trehalose;
2.25 +/-10 to 4.5 +/-10 weight percent of skimmed milk powder;
1.125 +/-10% to 2.25 +/-10% by weight of mannitol;
0.0225 +/-10% to 0.1125 +/-10% by weight of vitamin C;
0.225 plus or minus 10 percent to 1.125 plus or minus 10 percent of sodium glutethionine by weight;
0.225 plus or minus 10 percent to 1.125 plus or minus 10 percent of glycerol by weight; and
inevitable impurities contained in the above components after purification.
10. The starter protectant formulation of any of claims 1-5, wherein the skimmed milk powder is less than 4.5 parts by weight and the mannitol is less than 2.25 parts by weight.
11. Use of a starter protectant formulation according to claim 1 in the culture of gram-positive bacteria.
12. The use according to claim 11, wherein the gram-positive bacterium is a yeast.
13. Use of a starter protectant formulation according to claim 1 in the culture of gram-negative bacteria.
14. The use of claim 13, wherein the gram-negative bacterium is pseudomonas putida (c), (d) and d) b) anPseudomonas putida)。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW109107489 | 2020-03-06 | ||
TW109107489A TWI737210B (en) | 2020-03-06 | 2020-03-06 | Starter culture protection formula and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113355254A true CN113355254A (en) | 2021-09-07 |
CN113355254B CN113355254B (en) | 2024-05-03 |
Family
ID=77524419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010311191.9A Active CN113355254B (en) | 2020-03-06 | 2020-04-20 | Formula and application of screwdriver protective agent |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113355254B (en) |
TW (1) | TWI737210B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024015884A1 (en) * | 2022-07-12 | 2024-01-18 | Indigo Ag, Inc. | Endophyte compositions and methods for improved plant health |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101016527A (en) * | 2007-02-02 | 2007-08-15 | 丽珠医药集团股份有限公司 | Bifidobacteria viable bacteria preparation and special-purpose protective agent thereof |
CN101024818A (en) * | 2006-02-22 | 2007-08-29 | 财团法人食品工业发展研究所 | Wine brewing yeast strain for high-yield glutathione and its precursor and using method therefor |
TW200732471A (en) * | 2006-02-22 | 2007-09-01 | Food Industry Res & Dev Inst | Saccharomyces cerevisiae strains for hyper-producing glutathione and γ-glutamylcysteine and processes of use |
WO2007141102A1 (en) * | 2006-06-02 | 2007-12-13 | Symrise Gmbh & Co. Kg | Use of diacetyl dimer as an aromatic and/or flavouring substance |
CN101948779A (en) * | 2010-08-31 | 2011-01-19 | 天津启仁医药科技有限公司 | Preparation and use of solid microbial enzyme preparation for producing L-cysteine through enzymatic conversion |
US20160183578A1 (en) * | 2014-12-23 | 2016-06-30 | Celanese Sales Germany Gmbh | Taste modifying compositions |
CN106244459A (en) * | 2016-08-31 | 2016-12-21 | 沈阳化工研究院有限公司 | A kind of pseudomonas dry powder and preparation method thereof |
WO2019010282A1 (en) * | 2017-07-07 | 2019-01-10 | Osel, Inc. | High potency stable formulations of vaginal lactobacillus |
CN111849781A (en) * | 2020-08-21 | 2020-10-30 | 上海荣盛生物药业有限公司 | Streptococcus pneumoniae freeze-drying protective agent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012076665A1 (en) * | 2010-12-10 | 2012-06-14 | Dsm Ip Assets B.V. | Starter culture compositions |
CN107828683B (en) * | 2017-11-08 | 2021-09-07 | 江苏微康生物科技有限公司 | Lactobacillus plantarum freeze-dried powder capable of prolonging shelf life of yogurt and preparation method thereof |
-
2020
- 2020-03-06 TW TW109107489A patent/TWI737210B/en active
- 2020-04-20 CN CN202010311191.9A patent/CN113355254B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101024818A (en) * | 2006-02-22 | 2007-08-29 | 财团法人食品工业发展研究所 | Wine brewing yeast strain for high-yield glutathione and its precursor and using method therefor |
TW200732471A (en) * | 2006-02-22 | 2007-09-01 | Food Industry Res & Dev Inst | Saccharomyces cerevisiae strains for hyper-producing glutathione and γ-glutamylcysteine and processes of use |
WO2007141102A1 (en) * | 2006-06-02 | 2007-12-13 | Symrise Gmbh & Co. Kg | Use of diacetyl dimer as an aromatic and/or flavouring substance |
CN101016527A (en) * | 2007-02-02 | 2007-08-15 | 丽珠医药集团股份有限公司 | Bifidobacteria viable bacteria preparation and special-purpose protective agent thereof |
CN101948779A (en) * | 2010-08-31 | 2011-01-19 | 天津启仁医药科技有限公司 | Preparation and use of solid microbial enzyme preparation for producing L-cysteine through enzymatic conversion |
US20160183578A1 (en) * | 2014-12-23 | 2016-06-30 | Celanese Sales Germany Gmbh | Taste modifying compositions |
CN106244459A (en) * | 2016-08-31 | 2016-12-21 | 沈阳化工研究院有限公司 | A kind of pseudomonas dry powder and preparation method thereof |
WO2019010282A1 (en) * | 2017-07-07 | 2019-01-10 | Osel, Inc. | High potency stable formulations of vaginal lactobacillus |
CN111849781A (en) * | 2020-08-21 | 2020-10-30 | 上海荣盛生物药业有限公司 | Streptococcus pneumoniae freeze-drying protective agent |
Non-Patent Citations (1)
Title |
---|
张云光;岳田芳;梁莲华;黄金坚;罗石林;: "海藻糖在微生态制剂中的应用", 广西轻工业, no. 08 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024015884A1 (en) * | 2022-07-12 | 2024-01-18 | Indigo Ag, Inc. | Endophyte compositions and methods for improved plant health |
Also Published As
Publication number | Publication date |
---|---|
TWI737210B (en) | 2021-08-21 |
CN113355254B (en) | 2024-05-03 |
TW202134423A (en) | 2021-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2625982C (en) | Composition comprising enzymatically digested yeast cells and method of preparing same | |
CN107034163B (en) | Novel pediococcus acidilactici and application thereof | |
US10227571B2 (en) | Lactobacillus plantarum bacteriophage Lac-PLP-1 and use thereof for inhibiting Lactobacillus plantarum proliferation | |
US10227570B2 (en) | Lactobacillus brevis bacteriophage Lac-BRP-1 and use thereof for inhibiting Lactobacillus brevis proliferation | |
CN113170842A (en) | Composite microecological preparation for preventing and treating necrotic enteritis of poultry and application thereof | |
CN107937305B (en) | Butyric acid-resistant strong-stress-resistant clostridium butyricum microbial inoculum and application thereof | |
CN113736716B (en) | Lactobacillus paracasei, compound biological leavening agent for yellow storage and yellow storage method | |
CN112980735B (en) | Clostridium butyricum, microbial inoculum, application of clostridium butyricum and microbial inoculum and preparation method of microbial inoculum | |
CN103013890B (en) | Method of culturing lactobacillus and bacillus in mixing way | |
Gray et al. | The use of potassium tellurite, sodium azide, and acetic acid in a selective medium for the isolation of Listeria monocytogenes | |
CN112391325A (en) | Lactobacillus paracasei and application thereof | |
CN110295126B (en) | Mixed probiotic preparation and preparation process thereof | |
CN113355254A (en) | Formula and application of starter protective agent | |
CN107691849B (en) | Feed prepared by microbial fermentation | |
KR100396022B1 (en) | Probiotic composite for Livestock and Method therefor | |
Kumari et al. | Production, purification and efficacy of bacteriocin isolated from natural lactic acid fermentation of wild Himalayan fig fruit | |
CN108546661B (en) | Application method and preparation method of bacteriostatic microbial starter | |
CN113265352B (en) | Preparation method and application of enterococcus faecium powder | |
CN112391317B (en) | Probiotic bacterial strain composition for producing cubilose acid and application | |
CN114214263A (en) | Method for promoting clostridium butyricum to form spores, and microecological preparation and application thereof | |
KR20210040743A (en) | Additive advantage for the deodorant analysis | |
CN113583916B (en) | Bacillus keep-alive agent and application thereof | |
CN115261298A (en) | Domestication method of high-temperature-resistant lactobacillus plantarum and preparation method of lactobacillus plantarum powder | |
CN106434407A (en) | Preparation method of bacillus amyloliquefaciens Y1 live bacteria preparation | |
CN115354005A (en) | Compound microbial preparation and preparation method and storage method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |